JAMILA NEWSOME: Open Payments
NPI 1083223135 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 15 payments from 9 companies in 2025. Trend: 2023 $406 · 2024 $737 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $243 |
| Gilead Sciences, Inc. | 2 | $241 |
| Sumitomo Pharma America, Inc. | 5 | $164 |
| Amgen Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $122 |
| Astellas Pharma US Inc | 1 | $103 |
| Exact Sciences Corporation | 1 | $90 |
| Biogen, Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $23 |
Products named: GEMTESA, OTEZLA, BREZTRI, AIRSUPRA, Biktarvy, Korlym, Epclusa, Veozah.
Industry payments across GA — which companies pay providers there.
